Skip to search formSkip to main contentSkip to account menu

BMD 188

Known as: BMD-188, BMD188 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
A newly synthesized cyclic hydroxamic acid compound, BMD188 [cis-l-hydroxy-4-(l-naphthyl)-6-oc-tylpiperidine-2-one], was found to… 
Highly Cited
1999
Highly Cited
1999
We recently developed a class of novel anti-prostate cancer compounds, cyclic hydroxamates that elicit a potent apoptotic… 
1999
1999
BACKGROUND Prostate cancer is the most frequently diagnosed malignancy in the Western countries. Apoptosis-targeted drug… 
1999
1999
BACKGROUND In the preceding paper, we demonstrated that, BMD188 [cis-1-hydroxy-4-(1-naphthyl)-6-octylpiperidine-2-one], a newly… 
Highly Cited
1998
Highly Cited
1998
Cytochrome c release from mitochondria to and subsequent accumulation in the cytosol has been considered a prerequisite for…